| CORCEPT THERAPEUTICS INC. |
| USA |
| Gesundheit |
| US2183521028 / 529882 |
| HTD (Frankfurt) / CORT (NASDAQ) |
| FRA:HTD, ETR:HTD, HTD:GR, NASDAQ:CORT |
| - |
| https://www.corcept.com/ |
|
Corcept Therapeutics Incorporated is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing drugs that modulate cortisol effects to treat severe endocrinologic, metabolic, oncologic, and neurologic disorders..
>Volltext.. |
| 3721.28 Mio. EUR |
| 3413.26 Mio. EUR |
| 652.05 Mio. EUR |
| 39.98 Mio. EUR |
| 84.06 Mio. EUR |
| 0.81 EUR |
| 5.23 Mio. EUR |
| 103.19 Mio. EUR |
| 121.6 Mio. EUR |
| 2.24 |
| -0.58% |
| -38.07% |
| - |
| - |
| - |
| CORCEPT THERAPEUTICS, CORCEPT THERAPEUTIC |
| 09.04.26 |